Salt Lake City, Utah (Oct. 17, 2016) – At the American Society for Reproductive Medicine annual conference, industry-leading medical research from Fertility Centers of Illinois will present innovative findings and treatment technologies that advance effective infertility treatment for those everywhere looking to grow a family. The research will be presented to thousands of national and international fertility industry specialists in a series of oral presentations and poster presentations.

Research presentations will cover a variety of topics such as analyzing success rates against differing treatment approaches to similar infertility diagnoses, racial disparities with positive IVF outcomes in donor egg recipients, and an analysis of donor egg treatment regimens.

“Medical research is critical to offering the most effective treatment options for patients across the spectrum of infertility diagnoses,” says Dr. Meike Uhler, Director of Research at Fertility Centers of Illinois. “Our research places a spotlight on racial disparities in IVF, outcome success with donor egg, recurrent miscarriage and so much more. We look forward to sharing our findings with the medical community and helping patients fulfill their dream of parenthood.”

ASRM Presentation Summary:

Tuesday, Oct. 18

  • Poster Presentation: Temporal changes in oocyte donor treatment regimens in a real-world analysis of a U.S. database of 7,971 donor cycles over 6.5 years

Summary: The paper to be presented is one of the largest studies ever completed looking at optimizing stimulation protocols in order to maximize outcomes to intended parents and safety to egg donors.
Dr. Brian Kaplan, Fertility Centers of Illinois

7:00-8:45 a.m.

  • Oral Presentation: Is preimplantation genetic screening with frozen single embryo transfer superior to fresh in-vitro fertilization with elective single embryo transfer in a good prognosis population?

Summary: In women less than 38 years old who underwent fresh IVF with careful visual selection of the single best embryo on day five, ongoing pregnancy rates were similar to women who underwent PGS/sFET with euploidy as guidance for embryo selection. While the use of PGS may confer other benefits, it was not found to increase ongoing pregnancy rates in a good prognosis population.

Dr. Meike Uhler of Fertility Centers of Illinois is a senior author of the study.

Presenter: Dr. Ann Schufreider, OB/GYN Dept of University of Chicago

12:15 p.m.

Wednesday, Oct. 19

  • Poster Presentation: Does intralipid infusion improve outcomes in RPL (recurrent pregnancy loss)/RIF (recurrent implantation failure) patients undergoing IVF? Is it cost-effective?

Summary: Intralipids have been used to optimize success in patients with recurrent implantation failure and pregnancy loss. Our review of 300 patients demonstrated no improvement from this technology. It is important to focus on cost-effective treatments with evidence-based success.
Dr. Hirshfeld-Cytron, Fertility Centers of Illinois

7:00-8:45 a.m.

  • Poster Presentation: Impact of race on oocyte donation

Summary: There were no differences in ovarian responsiveness or number of oocytes retrieved between different racial groups. This information can be used clinically to reassure donor oocyte recipients regarding overall excellent prognosis with oocyte donation cycles.

Dr. Meike Uhler of Fertility Centers of Illinois is a senior author of the study.
Presenter: Dr. Diana Zhou, OB/GYN Dept of University of Chicago

7:00-8:45 a.m.

  • Oral Presentation: Racial Disparities: In vitro fertilization (IVF) outcomes in donor oocyte recipients
    Summary: Black women undergoing oocyte donation had a reduced likelihood of achieving pregnancy and a trend toward a reduced live birth rate. Asian and Hispanic women undergoing oocyte donation did not have reductions in clinical pregnancy rates or live birth rates compared to White women. Further studies are needed to better understand the pervasiveness of racial disparity in IVF outcomes.

Dr. Meike Uhler of Fertility Centers of Illinois is a senior author of the study.
Presenter: Dr. Diana Zhou, OB/GYN Dept of University of Chicago

11:45 a.m.


Salt Palace Convention Center
100 S W Temple
Salt Lake City, UT 84101

All poster presentations are in the conference center next to the exhibit hall.

# # #

Fertility Centers of Illinois (FCI) is one of the leading fertility treatment practices in the United States, providing advanced reproductive endocrinology services for over 30 years with more than 35,000 babies born. FCI physicians, embryologists and support staff are stringently chosen based on educational background, medical skills and their ability to collaborate. With a team of nine nationally and internationally recognized physicians who treat thousands of patients each year, the practice has earned a reputation for overcoming hard-to-solve fertility issues. FCI is dedicated to medical and clinical excellence and continues to invest in the latest technologies and research. FCI offers a comprehensive range of fertility treatment options including intrauterine insemination, in vitro fertilization, donor egg, gestational carrier and preimplantation genetic diagnosis, as well as extensive resources to address financial and emotional needs. As the premier fertility practice in the Midwest region, Fertility Centers of Illinois has eight physician offices and two monitoring locations serving patients in the Chicagoland region, northern Indiana and southern Wisconsin. Learn more by calling 877-324-4483 or visiting